KREATECH's Universal Linkage System (ULS(TM)) allows for the rapid attachment of a variety of labels directly to DNA, RNA and proteins. These products are centered around a proprietary platinum-based system that produces highly stable labels under a wide variety of conditions. The ULS(TM) products are available with a wide variety of industry standard dyes, offering a versatile solution for the labeling of RNA in microarray and DNA in CGH applications.

"This agreement expands our reach by leveraging BioCat's strong sales and marketing team in Germany, Switzerland and Austria" said Alexander Altink, KREATECH's CEO. "We look forward to working with BioCat and expanding our international distribution network. In the last two month's we closed similar agreements with BIOKE for the Benelux, Open Biosystems for the USA, Essen-Haus for Malaysia, INBIO for Australia and Sciencewerke for Singapore. In the next coming month's we expect to expand our distribution network furthermore, both in Europe and Asia. to reach a total of 20 business partners worldwide."

"This agreement enables us to provide our customers in academia and in industry with the most stable and reproducible labelling system for both nucleic acids and proteins we are aware of. Kreatech's ULS products are an ideal complement of our portfolio, as BioCat is always striving to supply life science researchers with the most innovative solutions" said Dr. Michael Ehret of BioCat.

About KREATECH Biotechnology

KREATECH Biotechnology B.V., a private company founded in 1990, focuses on the creation, development, production and marketing of innovative diagnostic and life science products. KREATECH's proprietary Universal Linkage System (ULS(TM)) offers a reliable, robust and easy to use non- enzymatic technology that can be applied to a broad range of biomolecules and labeling agents. KREATECH is committed to achieve and maintain the highest standards in production and Quality Control as well as in the relationships with our customers and partners. The company's quality policies are demonstrated by the implementation of ISO 9001 (2000) and ISO 13485 (GMP 2003) guidelines. More information on KREATECH can be accessed at www.kreatech.com

About BioCat

BioCat GmbH, a private company located in the Technologiepark Heidelberg and founded in 2000, concentrates on sales and marketing of innovative reagents for life science researchers in the German speaking market. The distributed products are manufactured by BioCat's partners in USA, Asia, Finland, the Netherlands, and Germany.